| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/13/2009 | US7476442 Nanoparticle chains and preparation thereof |
| 01/13/2009 | US7476391 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/13/2009 | US7476390 Polypeptides and polynucleotides useful in methods of inducing immune response against flaviviruses, including dengue viruses |
| 01/13/2009 | US7476387 Chimeric empty viral-like particles derived from the infectious bursal disease virus (IBDV), process for their production and applications |
| 01/13/2009 | US7476384 Death domain containing receptor 4 antibody and methods |
| 01/13/2009 | CA2615372A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/13/2009 | CA2408972C Genes encoding plant transcription factors |
| 01/13/2009 | CA2374729C Novel organic anion transport proteins |
| 01/13/2009 | CA2185653C Stabilization of peptides and proteins for radiopharmaceutical use |
| 01/13/2009 | CA2105534C Tnf ligands |
| 01/08/2009 | WO2009005973A2 Synthetic gene for enhanced expression in e.coli |
| 01/08/2009 | WO2009005040A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 01/08/2009 | WO2009003621A1 Cho cell |
| 01/08/2009 | WO2008140582A3 Production of anti-microbial peptides |
| 01/08/2009 | WO2008079246A3 Cd44 antibodies |
| 01/08/2009 | WO2008055260A3 Glycolysis-inhibiting substances in cell culture |
| 01/08/2009 | WO2007117680A3 Methods and compositions for treating bacterial infection |
| 01/08/2009 | US20090013432 Plastidic phosphoglucomutase genes |
| 01/08/2009 | US20090013421 Genomic DNA fragments containing regulatory and coding sequences for the B2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments |
| 01/08/2009 | US20090012273 Method of Regenerating Elastic Fiber with the Use of Dance or Factor Enhancing the Expression Thereof |
| 01/08/2009 | US20090012032 novel human genes RNF43 whose expression is markedly elevated in colorectal cancers; genes and polypeptides encoded by the genes can be used in the diagnosis of a cell proliferative disease, and as target molecules for developing drugs against the disease |
| 01/08/2009 | US20090012024 Stem Cell Markers |
| 01/08/2009 | US20090012003 Polypeptides homologous to vegf and bmp1 |
| 01/08/2009 | US20090011995 Production of a soluble native form of recombinant protein by the signal sequence and secretional enhancer |
| 01/08/2009 | US20090011992 Human Coagulation Factor VII Polypeptides |
| 01/08/2009 | US20090011983 186 Human Secreted Proteins |
| 01/08/2009 | US20090011981 Novel Inhibitors of Angiogenesis |
| 01/08/2009 | US20090011957 Ligational encoding using building block oligonucleotides |
| 01/08/2009 | US20090011499 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
| 01/08/2009 | US20090011490 Immunogenic minicells and methods of use |
| 01/08/2009 | US20090011468 Method for improving protein production |
| 01/08/2009 | US20090011467 Novel fructosyl peptide oxidase |
| 01/08/2009 | US20090011466 Concatameric immunoadhesion molecule |
| 01/08/2009 | US20090011465 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells |
| 01/08/2009 | US20090011464 Humanized immunoglubulin reactive with alph4beta7 integrin |
| 01/08/2009 | US20090011463 Pcka Modifications and Enhanced Protein Expression in Bacillus |
| 01/08/2009 | US20090011462 Polypeptides having Lipase Activity and Polynucleotides Encoding Same |
| 01/08/2009 | US20090011461 Human Spasmolytic Polypeptide in Glycosylated Form |
| 01/08/2009 | US20090011460 Calcium-binding photoprotein, gene encoding the same, and use thereof |
| 01/08/2009 | US20090011459 Process for producing functional non-naturally occurring proteins, and method for site-specific modification and immobilization of the proteins |
| 01/08/2009 | US20090011453 Methods for Producing Proteins Using Hamster Igf-1 |
| 01/08/2009 | US20090011409 Antibodies Against Cells of Fetal Origin |
| 01/08/2009 | US20090011036 Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance |
| 01/08/2009 | US20090011000 Inhibitors of Infection |
| 01/08/2009 | US20090010951 Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same |
| 01/08/2009 | US20090010950 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 01/08/2009 | US20090010946 Novel Stromal Cell-Derived Factor-1 Polypeptides, Polynucleotides, Modulators Thereof and Methods of Use |
| 01/08/2009 | US20090010943 Peptides associated with HLA-DR MHC class II molecule and involved in Rheumatoid arthritis |
| 01/08/2009 | US20090010942 Novel primate chitinases and uses therefor |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010925 Antibody variants |
| 01/08/2009 | US20090010924 Apoptotic Anti-IgE Antibodies |
| 01/08/2009 | US20090010921 Antigen binding molecules with increased Fc receptor binding affinity and effector function |
| 01/08/2009 | US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 01/08/2009 | US20090010879 Receptor Based Antagonists and Methods of Making and Using |
| 01/08/2009 | US20090010875 IL-7 Fusion Proteins |
| 01/08/2009 | US20090010872 Chimeric soluble hyper il-11 and use thereof |
| 01/08/2009 | US20090010843 Methods of Identifying Antibodies to Ligands of Orphan Receptors |
| 01/08/2009 | US20090010841 Antiproliferative agents; as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site; single chain antibody |
| 01/08/2009 | CA2692412A1 Treatment for anxiety |
| 01/08/2009 | CA2691626A1 Pseudomonas aeruginosa-outer membrane protein pa4710 |
| 01/08/2009 | CA2690538A1 Par-2 binding antibodies |
| 01/08/2009 | CA2689155A1 Cho cell |
| 01/07/2009 | EP2011886A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/07/2009 | EP2011880A1 Taurine transporter gene |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011873A2 Tumor necrosis factor receptor-associated factors |
| 01/07/2009 | EP2011870A1 Mutant polypeptide having effector function |
| 01/07/2009 | EP2011869A1 Novel anti-cd98 antibody |
| 01/07/2009 | EP2011862A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture |
| 01/07/2009 | EP2011802A2 Anti-CD40 monoclonal antibody |
| 01/07/2009 | EP2011514A1 A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 01/07/2009 | EP2011510A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 01/07/2009 | EP2010665A2 Bivalent erbb ligand binding molecules and methods for their preparation and use |
| 01/07/2009 | EP1532239B1 Methods and compositions for targeting secretory lysosomes |
| 01/07/2009 | EP1505149B1 Methylotroph yeast producing mammalian type sugar chain |
| 01/07/2009 | EP1474434B1 The eaat2 promoter and uses thereof |
| 01/07/2009 | EP1409684B1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/07/2009 | EP1385545B1 Humanized antibodies recognizing the beta-amyloid peptide |
| 01/07/2009 | EP1220933B1 Purification of recombinant proteins fused to multiple epitopes |
| 01/07/2009 | EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/07/2009 | EP1198581B1 Method for reducing the antigenicity of adeno-associated virus structural protein |
| 01/07/2009 | EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof |
| 01/07/2009 | EP1124984B1 Host cells expressing recombinant human erythropoietin |
| 01/07/2009 | EP1115874B1 Alzheimer's disease secretase |
| 01/07/2009 | EP1009725B1 13c,15n,2h labeled proteins for nmr structure determinations and their preparation |
| 01/07/2009 | EP0759985B1 Transgenic arthritic mice |
| 01/07/2009 | EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 01/07/2009 | CN101340929A Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye |
| 01/07/2009 | CN101337986A Artificial recombined hexon protein A, constructing method thereof and use |
| 01/07/2009 | CN100448997C Expression vector and application |
| 01/07/2009 | CN100448994C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 01/07/2009 | CN100448993C Interferon-like protein zcyto 21 |
| 01/07/2009 | CN100448992C Artificial human chromosome containing human antibody lambda light chain gene |
| 01/07/2009 | CN100448893C Humanized antibodies that recognize beta amyloid peptide |
| 01/07/2009 | CN100448890C Novel protein and process for producing same |
| 01/07/2009 | CN100448889C Cytotoxic depsipeptides |
| 01/07/2009 | CN100448486C Use of P2Y purinergic receptor expression for identifying preneoplastic and neoplastic states |